Angiogenesis, adipokines and breast cancer

Cytokine and Growth Factor Reviews

Volumn 20, Issue 3, 2009, Pages 193-201

  Vona Davis, Linda ^a   Rose, David P ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Adipokines; Angiogenesis; Breast cancer; Cytokines; Obesity

Indexed keywords

ADIPOCYTOKINE; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 6; LEPTIN; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADIPOGENESIS; ADIPOSE TISSUE; ANGIOGENESIS; BREAST CANCER; CANCER GROWTH; CANCER RELAPSE; CELL GROWTH; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; MACROPHAGE; METASTASIS; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM;

ADIPOKINES; ADIPOSE TISSUE; BREAST NEOPLASMS; CYTOKINES; FEMALE; HUMANS; LEPTIN; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67349101253     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2009.05.007     Document Type: Review

References (98)

1. Stephenson G.D., and Rose D.P. Breast cancer and obesity: an update. Nutr Cancer 45 (2003) 1-16
2. Engels K., Fox S.B., and Harris A.L. Angiogenesis is a biologic and prognostic indicator in human breast carcinoma. EXS 79 (1997) 113-156
3. Uzzan B., Nicolas P., Cucherat M., and Perret G.Y. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64 (2004) 2941-2955
4. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117 (2007) 2362-2368
5. Dvorak H.F. Angiogenesis: update 2005. J Thromb Haemost 3 (2005) 1835-1842
6. Brakenhielm E., Cao R., Gao B., Angelin B., Cannon B., Parini P., et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 94 (2004) 1579-1588
7. Neels J.G., Thinnes T., and Loskutoff D.J. Angiogenesis in an in vivo model of adipose tissue development. FASEB J 18 (2004) 983-985
8. Castellot Jr. J.J., Karnovsky M.J., and Spegelman B.M. Differentiation-dependent stimulation of neovascularization and endothelial cell chemotaxis by 3T3 adipocytes. Proc Natl Acad Sci USA 79 (1982) 5597-5601
9. Silverman K.J., Lund D.P., Zetter B.R., Lainey L.L., Shahood J.A., Freiman D.G., et al. Angiogenic activity of adipose tissue. Biochem Biophys Res Commun 153 (1988) 347-352
10. Bouloumie A., Sengenes C., Portolan G., Galitzky J., and Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50 (2001) 2080-2086
11. Mignatti P., and Rifkin D.B. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49 (1996) 117-137
12. Simons P.J., van den Pangaart P.S., van Rooman C.P., Aerts J.M., and Boon L. Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-α and interleukin-1β-treated human preadipocytes are potent leptin producers. Cytokine 32 (2005) 94-103
13. Teichert-Kuliszewska K., Hamilton B.S., Deitel M., and Roncari D.A. Augmented production of heparin-binding mitogenic proteins by preadipocytes from massively obese persons. J Clin Invest 90 (1992) 1226-1231
14. Bell L.N., Ward J.L., Degawa-Yamauchi M., Bovenkerk J.E., Jones R., Cacucci B.M., et al. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab 291 (2006) E843-E848
15. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapototic factors by human adipose stromal cells. Circulation 109 (2004) 1292-1298
16. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
17. Sunderkotter C., Steinbrink K., Goebeler M., Bhardwaj R., and Sorg C. Macrophages and angiogenesis. J Leukoc Biol 55 (1994) 410-422
18. Matsumoto S., Kishida K., Shimomura I., Maeda N., Nagaretani H., Matsuda M., et al. Increased plasma HB-EGF associated with obesity and coronary artery disease. Biochem Biophys Res Commun 292 (2002) 781-786
19. Lewis C.E., and Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res 66 (2006) 605-612
20. Huang L., and Li C. Leptin: a multifunctional hormone. Cell Res 10 (2000) 81-92
21. Vona-Davis L., Howard-McNatt M., and Rose D.P. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8 (2007) 395-408
22. Rose D.P., Gilhooly E.M., and Nixon D.W. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int J Oncol 21 (2002) 1285-1292
23. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., et al. Biological action of leptin as an angiogenic factor. Science 281 (1998) 1683-1686
24. Bouloumie A., Drexler H.C., Lafontan M., and Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83 (1998) 1059-1066
25. Park H.Y., Kwon H.M., Lim H.J., Hong B.K., Lee J.Y., Park B.E., et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33 (2001) 95-102
26. Artwohl M., Roden M., Holzenbein T., Freudenthaler A., Waldhausl W., and Baumgartner-Parzer S.M. Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obes Relat Metab Disord 26 (2002) 577-580
27. Anagnostoulis S., Karayiannakis A.J., Lambropoulou M., Efthimiadou A., Polychronidis A., and Simpoulos C. Human leptin induces angiogenesis in vivo. Cytokine 42 (2008) 353-357
28. Cao R., Brakenhielm E., Wahlestedt C., Thyberg J., and Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 98 (2001) 6390-6395
29. Ribatti D., Nico B., Belloni A.S., Vacca A., Roncali L., and Nussdorfer G.G. Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. Int J Mol Med 8 (2001) 265-268
30. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
31. Gerber H.-P., Dixit V., and Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A 1 in vascular endothelial cells. J Biol Chem 273 (1998) 13313-13316
32. Bauer S.M., Bauer R.J., Liu Z.J., Chen H., Goldstein L., and Velazquez O.C. Vascular endothelial growth factor-c promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels. J Vasc Surg 41 (2005) 699-707
33. Maumus M., Sengenes C., Decaunes P., Zararoff-Girard A., Bourlier V., Lafontan M., et al. Evidence for the in situ proliferation of adult adipose tissue-derived progenitor cells: influence of fat mass microenvironment and growth. J Clin Endocrinol Metab 93 (2008) 4098-4106
34. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., Hashimoto N., and Saito Y. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 46 (2003) 1483-1488
35. Fukumura D., Ushiyama A., Duda D.G., Xu L., Tam J., Krishna V., et al. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 93 (2003) e88-e97
36. Mick G.J., Wang X., and McCormick K. White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 143 (2002) 948-953
37. Marra K.G., Defail A.J., Clavijo-Alvarez J.A., Badylak S.F., Taieb A., Schipper B., et al. FGF-2 enhances vascularization for adipose tissue engineering. Plast Reconstr Surg 121 (2008) 1153-1164
38. Sauter E.R., Scott S., Hewett J., Kliethermes B., Ruhlen R.L., Basarakodu K., et al. Biomarkers associated with breast cancer are associated with obesity. Cancer Detect Prev 32 (2008) 149-155
39. Vona-Davis L., and Rose D.P. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14 (2007) 189-206
40. Goto F., Goto K., Weindel K., and Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69 (1993) 508-517
41. Burbridge M.F., Coge F., Galizzi J.P., Boutin J.A., West D.C., and Tucker G.C. The role of the matrix metalloproteinases during in vitro vessel formation. Angiogenesis 5 (2002) 215-226
42. Montesano R., Vassalli J.D., Baird A., Guillemin R., and Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83 (1986) 7297-7301
43. Herbert J.M., Laplace M.C., and Maffrand J.P. Effect of heparin on the angiogenic potency of basic and acidic fibroblast growth factors in the rabbit cornea assay. Int J Tissue React 10 (1988) 133-139
44. Ribatti D., Nico B., Morbidelli L., Donnini S., Ziche M., Vacca A., et al. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. J Vasc Res 38 (2001) 389-397
45. Matsumoto K., Nakamura T., Sakai K., and Nakamura T. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4. Proteomics 8 (2008) 3360-3370
46. Bussolino F., Di Renzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119 (1992) 629-641
47. Rosen E.M., Lamszus K., Laterra J., Polverini P.J., and Rubin J.S. Goldberg ID HGF/SF in angiogenesis. Ciba Found Symp 212 (1997) 215-226
48. Maejima Y., Ueba H., Kuroki M., Yasu T., Hashimoto S., Nabata A., et al. Src family kinases and nitric oxide production are required for hepatocyte growth factor-stimulated endothelial cell growth. Atherosclerosis 167 (2003) 89-95
49. Bell L.N., Cai L., Johnstone B.H., Traktuev D.O., March K.L., and Considine R.V. A central role for hepatocyte growth factor in adipose tissue angiogenesis. Am J Physiol Endocrinol Metab 294 (2008) E336-E344
50. Tomita N., Morishita R., Taniyama Y., Koike H., Aoki M., Shimizu H., et al. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 107 (2003) 1411-1417
51. Laterra J., Nam M., Rosen E., Rao J.S., Lamszus K., Goldberg I.D., et al. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab Invest 76 (1997) 565-577
52. Abounader R., Lal B., Luddy C., Koe G., Davidson B., Rosen E.M., et al. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. FASEB J 16 (2002) 108-110
53. Raab G., and Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333 (1997) F179-F199
54. Abramovitch R., Neeman M., Reich R., Stein I., Keshet E., Abraham J., et al. Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Lett 425 (1998) 441-447
55. Mehta V.B., and Besner G.E. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors 25 (2007) 253-263
56. Ongusaha P.P., Kwak J.C., Zwible A.J., Macip S., Higashiyama S., Taniguchi N., et al. HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res 64 (2004) 5283-5290
57. Fang L., Li G., Liu G., and Lee S.W. Aaronson SA. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J 20 (2001) 1931-1939
58. Garcia-Maceda R., Sanchez-Munoz F., Almanza-Perez J.C., Duran-Reyes G., Alarcon-Aguilar F., and Cruz M. Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells. Eur J Pharmacol 587 (2008) 317-321
59. Himmerich H., Fulda S., Linseisen J., Seiler H., Wolfram G., Himmerich S., et al. TNF-α, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur Cytokine Netw 17 (2006) 196-201
60. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17 (1997) 4015-4023
61. Gao B., Saba T.M., and Tsan M.F. Role of α(v)β(3)-integrin in TNF-α-induced endothelial cell migration. Am J Physiol Cell Physiol 283 (2002) C1196-C1205
62. Fajardo L.F., Kwan H.H., Kowalski J., Prionas S.D., and Allison A.C. Dual role of tumor necrosis factor-α in angiogenesis. Am J Pathol 140 (1992) 539-544
63. Leibovich S.J., Polverini P.J., Shepard H.M., Wiseman D.M., Shively V., and Nuseir N. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature 329 (1987) 630-632
64. Rega G., Kaun C., Demyanets S., Pfaffenberger S., Rychli K., Hohensinner P.J., et al. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol 27 (2007) 1587-1595
65. Hernandez-Rodriguez J., Segarra M., Vilardell C., Sanchez M., Garcia-Martinez A., Estaban M.J., et al. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 107 (2003) 2428-2434
66. Ebrahem Q., Minamoto A., Hoppe G., Anand-Apte B., and Sears J.E. Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors. Invest Ophalmol Vis Sci 47 (2006) 4935-4941
67. Nilsson M.B., Langley R.R., and Fidler I.J. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 65 (2005) 10794-10800
68. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
69. Schraw T., Wang Z.V., Halberg N., Hawkins M., and Scherer P.E. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 149 (2008) 2270-2282
70. Matsuda M., Shimomura I., Sata M., Arita Y., Nishida M., Maeda N., et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 277 (2002) 37487-37491
71. Mahadev K., Wu X., Donnelly S., Ouedraogo R., Eckhart A.D., and Goldstein B.J. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res 78 (2008) 376-384
72. Brakenhielm E., Veitonmaki N., Cao R., Kihara S., Matsuzawa Y., Zhivotovsky B., et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 101 (2004) 2476-2481
73. Bora P.S., Kaliappan S., Lyzogubov V.V., Tytarenko R.G., Thotakura S., Viswanathan T., et al. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett 581 (2007) 1977-1982
74. Kumar P., Ning Y., and Polverini P.J. Endothelial cells expressing Bcl-2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion. Lab Invest 88 (2008) 740-749
75. Relf M., LeJeune S., Scott P.A., Fox S., Smith K., Leek R., et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factorβ-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57 (1997) 963-969
76. Smith K., Fox S.B., Whitehouse R., Taylor M., Greenall M., Clarke J., et al. Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival. Ann Oncol 10 (1999) 707-713
77. Hicklin D.J., and Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23 (2005) 1011-1027
78. Banerjee S., Dowsett M., Ashworth A., and Martin L.A. Mechanism of disease: angiogenesis and the management of breast cancer. Nat Clin Pract Oncol 4 (2007) 536-550
79. Schneider B.P., and Sledge Jr. G.W. Drug insight: VEGF as a therapeutic target for breast cancer. Nat Clin Pract Oncol 4 (2007) 181-189
80. Gonzalez R.R., Cherfils S., Escobar M., Yoo J.H., Carino C., Styer A.K., et al. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 281 (2006) 26320-26328
81. Ribatti D., Belloni A.S., Nico B., Di Comite M., Crivellato E., and Vacca A. Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma. Peptides 29 (2008) 1596-1602
82. Lamszus K., Jin L., Fuchs A., Shi E., Chowdhury S., Yao Y., et al. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest 76 (1997) 339-353
83. Zhang Y.W., Su Y., Volpert O.V., and Vande Woude G.F. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci USA 100 (2003) 12718-12723
84. Revillion F., Lhotellier V., Hornez L., Bonneterre J., and Peyrat J.P. Erb/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. Ann Oncol 19 (2008) 73-80
85. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17 (2006) 4-12
86. Gruen M.L., Hao M., Piston D.W., and Hasty A.H. Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. Am J Physiol Cell Physiol 293 (2007) C1481-C1488
87. Leek R.D., Hunt N.C., Landers R.J., Lewis C.E., Royds J.A., and Harris A.L. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190 (2000) 430-436
88. Bolat F., Kayaselcuk F., Nursal T.Z., Yagmurdur M.C., Bal N., and Demirhan B. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J Exp Clin Cancer Res 25 (2006) 365-372
89. Leek R.D., Lewis C.E., Whitehouse R., Greenall M., Clarke J., and Harris A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56 (1996) 4625-4629
90. Polverini P.J., and Leibovich S.J. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51 (1984) 635-642
91. Nilsson M.B., Armaiz-Pena G., Takahashi R., Lin Y.G., Trevino J., Li Y., et al. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J Biol Chem 282 (2007) 29919-29926
92. Turu M.M., Slevin M., Matou S., West D., Rodriguez C., Luque A., et al. C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signaling pathways and gene expression. BMC Cell Biol 9 (2008) 47
93. Jiang H., Yu J., Guo H., Song H., and Chen S. Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Biochem Biophys Res Commun 368 (2008) 1-5
94. Dos Santos E., Benaitreau D., Dieudonne M.N., Leneveu M.C., Serazin V., Giudicelli Y., et al. Adiponectin mediates an antiproliferative response in human MDA-MB-231 breast cancer cells. Oncol Rep 20 (2008) 971-977
95. Miyoshi Y., Funahashi T., Tanaka S., Taguchi T., Tamaki Y., Shimomura I., et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 118 (2006) 1414-1419
96. Ribatti D., Conconi M.T., and Nussdorfer G.G. Nonclassic endogenous regulators of angiogenesis. Pharmacol Rev 59 (2007) 185-205
97. Lang I., Hoffmann C., Olip H., Pabst M.A., Hahn T., Dohr G., et al. Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity. Cell Prolif 34 (2001) 143-155
98. Loi S., Milne R.L., Friedlander M.L., McCredie M.R., Giles G.G., Hopper J.L., et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1686-1691